Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China. (Q35871046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

title

Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

20 February 2020

main subject

0 references

1 reference

Yao He

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

Pingping Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

Yujun Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

Rongping Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

Baili Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

Zhirong Zeng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

Minhu Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

1 reference

15 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

International Journal of Clinical and Experimental Medicine

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

8078-8085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis.

20 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho university hospital

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Cutting edge: cure of colitis by CD4 CD25 regulatory T cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Interleukin 12 and Th1 responses in inflammatory bowel disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Peripheral and intestinal regulatory CD4 CD25(high) T cells in inflammatory bowel disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Hepatitis B and C virus infection in Crohn's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

CD4 CD25 Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4509318

Geographic distribution of HBsAg carriers in China

24 September 2018

1 reference

12 December 2020

[Technical guide for adult hepatitis B immunization in China].

1 reference

12 December 2020

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

1 reference

12 December 2020

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

1 reference

12 December 2020

Fulminant hepatic failure in chronic hepatitis B on withdrawal of corticosteroids, azathioprine and infliximab for Crohn's disease

1 reference

12 December 2020

Guideline on prevention and treatment of chronic hepatitis B in China (2005)

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221373 AND SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

26221373

1 reference